Assessment of economic humanistic and safety outcomes in patients receiving different anticancer regimens for breast head and neck and lung cancers

dc.contributor.guide	Parthasarathi, G
dc.coverage.spatial	Pharmacy
dc.creator.researcher	Sharma, Aakanksha
dc.date.accessioned	2020-09-10T15:12:48Z
dc.date.available	2020-09-10T15:12:48Z
dc.date.awarded	23/07/2020
dc.date.completed	2018
dc.date.registered	2015
dc.description.abstract	available
dc.description.note	quotsummary p 54-56, References 59-66 p quot
dc.format.accompanyingmaterial	CD
dc.format.dimensions	3
dc.format.extent	i-xiii, 1-87 p
dc.identifier.uri	http://hdl.handle.net/10603/298936
dc.language	English
dc.publisher.institution	Colleges of Pharmacy
dc.publisher.place	Mysore
dc.publisher.university	JSS Academy of Higher Education and Research
dc.relation	108
dc.rights	university
dc.source.university	University
dc.subject.keyword	Cancer, Drug Utilization Evaluation NCCN Guidelines, Anticancer agents, Anti-emetics, Compliance, Chemotherapy-induced Nausea and Vomiting
dc.subject.keyword	Clinical Pre Clinical and Health
dc.subject.keyword	Pharmacology and Pharmacy
dc.subject.keyword	Pharmacology and Toxicology
dc.title	Assessment of economic humanistic and safety outcomes in patients receiving different anticancer regimens for breast head and neck and lung cancers
dc.title.alternative
dc.type.degree	Ph.D.